Patents by Inventor Jordan Hunt

Jordan Hunt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bioenergetically active esters for health and disease
    Patent number: 11952337
    Abstract: Compounds, compositions, and methods related to bioenergetic metabolism are provided. The compounds and compositions are suited to promote bioenergetic processes including cellular respiration and glycolytic flux and may be used to treat mitochondrial disorders, neurodegenerative diseases (such as Alzheimer's disease (AD), Parkinson's disease, and/or amyotrophic lateral sclerosis), multiple sclerosis, and/or epilepsy.
    Type: Grant
    Filed: May 16, 2022
    Date of Patent: April 9, 2024
    Assignee: University of Kansas
    Inventors: Russell Swerdlow, Laird Forrest, Jordan Hunt, Heather Wilkins, Eli Michaelis
  • BIOENERGETICALLY ACTIVE ESTERS FOR HEALTH AND DISEASE
    Publication number: 20230109376
    Abstract: Compounds, compositions, and methods related to bioenergetic metabolism are provided. The compounds and compositions are suited to promote bioenergetic processes including cellular respiration and glycolytic flux and may be used to treat mitochondrial disorders, neurodegenerative diseases (such as Alzheimer's disease (AD), Parkinson's disease, and/or amyotrophic lateral sclerosis), multiple sclerosis, and/or epilepsy.
    Type: Application
    Filed: May 16, 2022
    Publication date: April 6, 2023
    Inventors: Russell Swerdlow, Laird Forrest, Jordan Hunt, Heather Wilkins, Eli Michaelis
  • Platinum(IV) conjugates and methods of use
    Patent number: 11458163
    Abstract: Provided are platinum(IV) compounds of Formula I or pharmaceutically acceptable salts thereof. Also provided are compositions including such compounds as well as methods of using the same.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: October 4, 2022
    Assignees: University of Kansas, HylaPharm, LLC
    Inventors: Laird Forrest, Daniel Aires, Ryan Moulder, Ruolin Lu, Jordan Hunt, Peter Kleindl, Ti Zhang, Chad Groer, Shuang Cai
  • IMIDAZOQUINOLINE COMPOUNDS AND PRODRUGS THEREOF
    Publication number: 20220177472
    Abstract: The present technology is directed to TLR7 and TLR8 agonist compounds, compositions, and methods of using the same for the treatment of cancers and as vaccine adjuvants.
    Type: Application
    Filed: April 16, 2020
    Publication date: June 9, 2022
    Applicants: UNIVERSITY OF KANSAS, HYLAPHARM, LLC.
    Inventors: Laird Forrest, Daniel Aires, Ryan Moulder, Ruolin Lu, Jordan Hunt, Peter Kleindl, Ti Zhang, Chad Groer, Shuang Cai
  • Bioenergetically active esters for health and disease
    Patent number: 11332432
    Abstract: Compounds, compositions, and methods related to bioenergetic metabolism are provided. The compounds and com positions are suited to promote bioenergetic processes including cellular respiration and glycolytic flux and may be used to treat mitochondrial disorders, neurodegenerative diseases (such as Alzheimer's disease (AD), Parkinson's disease, and/or amyotrophic lateral sclerosis), multiple sclerosis, and/or epilepsy.
    Type: Grant
    Filed: September 30, 2019
    Date of Patent: May 17, 2022
    Assignee: University of Kansas
    Inventors: Russell Swerdlow, Laird Forrest, Jordan Hunt, Heather Wilkins, Eli Michaelis
  • BIOENERGETICALLY ACTIVE ESTERS FOR HEALTH AND DISEASE
    Publication number: 20210317067
    Abstract: Compounds, compositions, and methods related to bioenergetic metabolism are provided. The compounds and com positions are suited to promote bioenergetic processes including cellular respiration and glycolytic flux and may be used to treat mitochondrial disorders, neurodegenerative diseases (such as Alzheimer's disease (AD), Parkinson's disease, and/or amyotrophic lateral sclerosis), multiple sclerosis, and/or epilepsy.
    Type: Application
    Filed: September 30, 2019
    Publication date: October 14, 2021
    Inventors: Russell Swerdlow, Laird Forrest, Jordan Hunt, Heather Wilkins, Eli Michaelis
  • PLATINUM(IV) CONJUGATES AND METHODS OF USE
    Publication number: 20200330507
    Abstract: Provided are platinum(IV) compounds of Formula I or pharmaceutically acceptable salts thereof. Also provided are compositions including such compounds as well as methods of using the same.
    Type: Application
    Filed: April 16, 2020
    Publication date: October 22, 2020
    Applicants: University of Kansas, HylaPharm, LLC
    Inventors: Laird Forrest, Daniel Aires, Ryan Moulder, Ruolin Lu, Jordan Hunt, Peter Kleindl, Ti Zhang, Chad Groer, Shuang Cai